Work

Solanezumab: too late in mild Alzheimer's disease?

Year: 2017

Type: editorial

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(16)30395-7

Author: The Lancet Neurology

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4248280011

Cites:

Cited by: 58

Related to: 10